https://www.news-medical.net/news/20220426/The-impact-of-leronlimab-on-CCR5-surface-cell-levels-during-long-COVID.aspx#:~:text=Conclusion,the manifestation of long COVID.

 

Since the company has decided not to pursue further studies for long Covid, you wonder if an academic group would want to take the results and design a new study.  There are an awful lot of people out there still suffering symptoms, to the point where it affects the U.S. economy due to loss of workforce.

 

Conclusion

The study findings showed that the immune down-modulation caused by long COVID was significantly reversed by treatment with leronlimab. The researchers believe that further extensive studies can ascertain the mechanism of CCR5 in the manifestation of long COVID.